News + Filings Transactions Holdings
|
Schall Thomas J.
Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
08/04/2022 | ChemoCentryx, Inc. | CCXI | Sale | Common Stock | 130k | $50.24 | $6.5M | | 08/04/2022 |
08/04/2022 | ChemoCentryx, Inc. | CCXI | Exercise | Stock Option (right to buy) | 130k | $14.28 | $1.9M | | 08/04/2022 |
02/22/2022 | ChemoCentryx, Inc. | CCXI | Grant | Restricted Stock Units | 152.7k | $0.00 | $0 | | 02/22/2022 |
02/22/2022 | ChemoCentryx, Inc. | CCXI | Grant | Stock Option (right to buy) | 192.6k | $29.83 | $5.7M | | 02/22/2022 |
01/01/2022 | ChemoCentryx, Inc. | CCXI | Payment of Exercise | Common Stock | 45.7k | $36.41 | $1.7M | | 01/01/2022 |
01/01/2022 | ChemoCentryx, Inc. | CCXI | Exercise | Restricted Stock Units | 23.3k | $0.00 | $0 | | 01/01/2022 |
01/01/2022 | ChemoCentryx, Inc. | CCXI | Exercise | Restricted Stock Units | 34.6k | $0.00 | $0 | | 01/01/2022 |
01/01/2022 | ChemoCentryx, Inc. | CCXI | Exercise | Restricted Stock Units | 26.3k | $0.00 | $0 | | 01/01/2022 |
12/01/2021 | ChemoCentryx, Inc. | CCXI | Exercise | Stock Option (right to buy) | 38.9k | $10.27 | $400k | | 12/01/2021 |
12/01/2021 | ChemoCentryx, Inc. | CCXI | Exercise | Stock Option (right to buy) | 7k | $14.31 | $100k | | 12/01/2021 |
02/25/2021 | ChemoCentryx, Inc. | CCXI | Grant | Restricted Stock Units | 79k | $0.00 | $0 | | 02/25/2021 |
02/25/2021 | ChemoCentryx, Inc. | CCXI | Grant | Stock Option (right to buy) | 54.6k | $65.87 | $3.6M | | 02/25/2021 |
01/01/2021 | ChemoCentryx, Inc. | CCXI | Payment of Exercise | Common Stock | 47.6k | $61.92 | $2.9M | | 01/01/2021 |
01/01/2021 | ChemoCentryx, Inc. | CCXI | Exercise | Restricted Stock Units | 30k | $0.00 | $0 | | 01/01/2021 |
01/01/2021 | ChemoCentryx, Inc. | CCXI | Exercise | Restricted Stock Units | 23.3k | $0.00 | $0 | | 01/01/2021 |
01/01/2021 | ChemoCentryx, Inc. | CCXI | Exercise | Restricted Stock Units | 34.6k | $0.00 | $0 | | 01/01/2021 |
12/15/2020 | ChemoCentryx, Inc. | CCXI | Sale | Common Stock | 17.6k | $65.01 | $1.1M | | 12/14/2020 |
12/15/2020 | ChemoCentryx, Inc. | CCXI | Exercise | Stock Option (right to buy) | 17.6k | $14.31 | $252.1k | | 12/14/2020 |
12/14/2020 | ChemoCentryx, Inc. | CCXI | Exercise | Stock Option (right to buy) | 11.2k | $14.31 | $159.6k | | 12/14/2020 |
12/14/2020 | ChemoCentryx, Inc. | CCXI | Sale | Common Stock | 11.2k | $65.03 | $725.2k | | 12/14/2020 |
06/15/2020 | ChemoCentryx, Inc. | CCXI | Exercise | Stock Option (right to buy) | 2k | $14.31 | $28.6k | | 06/12/2020 |
06/15/2020 | ChemoCentryx, Inc. | CCXI | Sale | Common Stock | 2k | $65.04 | $130.1k | | 06/12/2020 |
06/12/2020 | ChemoCentryx, Inc. | CCXI | Sale | Common Stock | 88.8k | $65.08 | $5.8M | | 06/12/2020 |
06/12/2020 | ChemoCentryx, Inc. | CCXI | Exercise | Stock Option (right to buy) | 88.8k | $14.31 | $1.3M | | 06/12/2020 |
05/12/2020 | ChemoCentryx, Inc. | CCXI | Sale | Common Stock | 35.9k | $57.75 | $2.1M | | 05/08/2020 |
05/12/2020 | ChemoCentryx, Inc. | CCXI | Exercise | Stock Option (right to buy) | 35.9k | $14.31 | $513.2k | | 05/08/2020 |
05/11/2020 | ChemoCentryx, Inc. | CCXI | Exercise | Stock Option (right to buy) | 70.6k | $14.31 | $1M | | 05/08/2020 |
05/11/2020 | ChemoCentryx, Inc. | CCXI | Sale | Common Stock | 54.6k | $55.33 | $3M | | 05/08/2020 |
05/11/2020 | ChemoCentryx, Inc. | CCXI | Sale | Common Stock | 16k | $56.14 | $899.9k | | 05/08/2020 |
05/08/2020 | ChemoCentryx, Inc. | CCXI | Exercise | Stock Option (right to buy) | 4.2k | $14.31 | $60.1k | | 05/08/2020 |
05/08/2020 | ChemoCentryx, Inc. | CCXI | Sale | Common Stock | 4.2k | $55.01 | $231.1k | | 05/08/2020 |
05/05/2020 | ChemoCentryx, Inc. | CCXI | Sale | Common Stock | 8.9k | $55.01 | $486.9k | | 05/05/2020 |
05/05/2020 | ChemoCentryx, Inc. | CCXI | Exercise | Stock Option (right to buy) | 8.9k | $14.31 | $126.7k | | 05/05/2020 |
03/04/2020 | ChemoCentryx, Inc. | CCXI | Sale | Common Stock | 40.8k | $50.35 | $2.1M | | 03/03/2020 |
03/04/2020 | ChemoCentryx, Inc. | CCXI | Exercise | Stock Option (right to buy) | 40.8k | $14.31 | $584.5k | | 03/03/2020 |
|
|